Todor Jeliaskov Appointed CEO of inHEART

inHEART, the leader in image guidance for treatment of cardiac arrhythmias, has appointed Todor Jeliaskov as CEO. He will lead the French company in its mission to bridge the gap between cardiology and medical imaging with a digital twin of the patient’s heart. Todor Jeliaskov will work closely with co-founder and former CEO Jean-Marc Peyrat, who transitions to the role of CTO at inHEART.

“I am thrilled to welcome Todor as our new CEO,” said Jean-Marc Peyrat, co-founder of inHEART. “His proven leadership and experience perfectly complement our existing team to scale up the company and to support its ambition to be a major player in the double-digit growing market of cardiac electrophysiology.”

Todor Jeliaskov brings over 20 years of experience solving customers’ needs and generating returns for investors and shareholders at large, complex enterprises and startup organizations across continents and various industries. Before inHEART, Todor Jeliaskov was CEO of NuVera Medical, acquired by Biosense Webster (Johnson & Johnson) in November 2020. NuVera developed the next-generation of ultrasound imaging technology for cardiac interventions – 4D ICE. Todor Jeliaskov previously served as VP at GE Ultrasound, the worldwide market leader in diagnostic ultrasound. Todor Jeliaskov started his career at Siemens Medical Solutions. He holds a Ph.D. in Electrical Engineering and an MBA degree.

“I am honored to join the exceptionally talented inHEART team that developed a unique solution for the guidance of cardiac ablations. It is rare to see new technologies with such a substantial impact on patient care.” said Todor Jeliaskov. “I am excited to be part of this revolution and I look forward to driving its international deployment to make it accessible to most patients.”

“At Elaia, we congratulate Todor Jeliaskov on his selection as Chief Executive Officer, we’re excited by the tremendous progress inHEART has made since Elaia’s investment in 2020 under Jean-Marc Peyrat’s leadership as CEO and would like to thank him and welcome him as the new Chief Technology Officer of the company,” said Samantha Jérusalmy, Partner at Elaia. “We are confident that inHEART is poised for strong growth and Todor’s commercial leadership and management experience are unique assets in this new phase.” explains Sacha Loiseau, Venture Partner at Elaia.

Other Executives In the News

SourceinHEART
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.
Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra's Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.
Christopher Slachta joins Cytovale after serving 12 years at Abbott, most recently as divisional vice president of global operations and supply chain, molecular diagnostics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy